Emory Eye Center

Atlanta, Georgia 30342

4 studies enrolling now · 32 studies all time

What they study most

AMD, Age Related Macular Degeneration, Anterior Uveitis, Brimonidine Tartrate, Choroidal Melanoma, Congenital Cataract, Cornea Transplant, Corneal Diseases, Corneal Graft Rejection, Corneal Transplantation, Deaf Blind, Diabetic Macular Edema

Studies at this site

• Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants — Recruiting now
• Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy — Recruiting now
• Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR — Recruiting now
• Rate of Progression in EYS Related Retinal Degeneration — Completed
• A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma — Running, not enrolling
• The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy — Completed
• Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma — Completed
• Infant Aphakia Treatment Study (IATS) — Completed
• Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) — Stopped early
• LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye — Stopped early
• Anti-VEGF Treatment for Prevention of PDR/DME — Completed
• Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease — Stopped early
• Definity for Ultrasound of Intraocular Tumors — Withdrawn before enrolling
• Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus — Completed
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO — Stopped early
• PROMINENT-Eye Ancillary Study (Protocol AD) — Stopped early
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema — Completed
• Treatment for CI-DME in Eyes With Very Good VA Study — Completed
• Post-Approval Study of the Implantable Miniature Telescope — Enrolling by invitation
• A Long-Term Monitoring Study of the IMT-002 Patients — Completed
• Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial — Completed
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) — Completed
• Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy — Completed
• Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP) — Withdrawn before enrolling
• Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis — Completed
• Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty — Stopped early
• Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk — Stopped early
• Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior Uveitis — Completed
• Herpetic Eye Disease Study (HEDS) II — Completed
• Complications of Age-Related Macular Degeneration Prevention Trial — Completed
• Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity — Stopped early